Scholar IQ
Try ScholarIQ free
Upload Records Snowball Search Search OpenAlex
About the database
ScholarIQanswers from OpenAlex

MEK inhibitors for neurofibromatosis type 1 manifestations: Clinical evidence and consensus

PaperCitations, authors & open-access status

MEK inhibitors for neurofibromatosis type 1 manifestations: Clinical evidence and consensus is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 102 citations, 2022 year and bronze oa status.

102
Citations
2022
Year
bronze
OA Status

Related on ScholarIQ

Andrea M. Gross
Author
Neurofibromatosis and Schwannoma Cases
Topic
Neurofibromatosis and Schwannoma Cases
Topic
Sarcoma Diagnosis and Treatment
Topic
Meningioma and schwannoma management
Topic
470M+ articles · free account